Biopol Chemicals IPO
Market Sentiment
Market Lot Size
IPO Details
IPO Reservation
Financial Analysis
| Metric | 2024 | 2025 | Dec 2025 |
|---|---|---|---|
| Revenue | 17.43 | 49.15 | 48.97 |
| Expense | 15.72 | 43.35 | 40.89 |
| Profit (PAT) | 2.96 | 4.33 | 6.00 |
| Total Assets | 17.56 | 31.48 | 48.88 |
| Company | P/E | EPS | Market Cap (Cr) |
|---|---|---|---|
| Rossari Biotech Limited | 20.93 | 24.63 | 16 |
| Fineotex Chemical Limited | 2.30 | 9.44 | 19 |
| Indian Emulsifiers Limited | 7.19 | 10.88 | 20 |
Promoters: Mr. Santanu Sarkar And Mr. Vedant Sarkar
| Shareholding | No. of Shares | Holding % |
|---|---|---|
| Promoter Holding Pre Issue | 79,11,000 | 89.88% |
| Promoter Holding Post Issue | 1,08,05,400 | 65.81% |
Company Information
Since its incorporation in 2023, Biopal Chemicals has been involved in the manufacturing and distribution of specialty chemicals like silicones, emulsifiers, biochemicals, and polyelectrolytes. Its products include 40 silicone-based products, 5 emulsifier-based products, 15 biochemical products, and 6 polyelectrolyte products. From textiles, home care, agriculture, to industrial chemicals, its products are used in various industries. Its 4 manufacturing facilities are located in Gujarat and West Bengal, which can manufacture up to 18,25,000 litres of products every year. Moreover, the business also provides technical consultancy services to customers. Furthermore, Bipol Chemicals follows a B2B model, catering to institutional clients instead of retail.
| Purpose | Amount (Cr) |
|---|---|
| Acquisition of industrial land | 12.26 |
| Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies | 11.10 |
| General Corporate Purpose | - |
Resources & Documents
Biopol Chemicals Ltd, D-211, 2nd Floor, Block-D,, Sumel Business Park-6 Near Dudheshwar Circle, Dudheshwar Tavdipura, Ahmedabad, Gujarat, 380004
Biopol Chemicals has set a price band of Rs 104–Rs 108 per share for an issue size of Rs 31 crore in the chemicals sector. The stock listed with a 2.78% gain versus its issue price on February 13, 2026.
Since its incorporation in 2023, Biopal Chemicals has been involved in the manufacturing and distribution of specialty chemicals like silicones, emulsifiers, biochemicals, and polyelectrolytes. Its products include 40 silicone-based products, 5 emulsifier-based products, 15 biochemical products, and 6 polyelectrolyte products. The company operates in the chemicals space.
The issue is promoted by Mr. Santanu Sarkar And Mr. Vedant Sarkar with Smart Horizon Capital Advisors Pvt. Ltd. acting as lead manager. Net proceeds will primarily be used towards Acquisition of industrial land (Rs 12 crore) and Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and… (Rs 11 crore).
Grey market is quoting a premium of +Rs 1 (+0.9% over issue price), down Rs 3 from the previous session. Final subscription data records overall subscription at 22.39x, retail at 20.80x, QIB at 21.05x, NII at 24.62x.
On fundamentals, the company is posting revenue growth of 182.0%, a profit margin of 8.8%, return on equity of 38.1% in its most recent reported period. Listed peers in this segment include Indian Emulsifiers Limited (P/E 7.19x, market cap Rs 20 crore) and Fineotex Chemical Limited (P/E 2.30x, market cap Rs 19 crore) — useful reference points when evaluating the issue's pricing relative to where the broader sector are trading.
Our data-driven engine currently flags this issue as a Neutral stance — the data is mixed and the risk-reward is balanced rather than one-sided. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
Understanding Grey Market Premium (GMP)
The Grey Market Premium (GMP) is an unofficial indicator of how an IPO's shares are trading in the grey market before they are officially listed on a stock exchange. It reflects investor sentiment and demand for the IPO shares ahead of listing day.
How does it work? The grey market is an informal, over-the-counter market where investors buy and sell IPO shares before the official listing date. If an IPO has a positive GMP, it suggests that investors expect the stock to list above its issue price. A negative GMP indicates expectations of a listing below the issue price.
Example: If an IPO has an issue price of ₹100 and the GMP is ₹50, the expected listing price would be approximately ₹150 (issue price + GMP). This translates to an estimated listing gain of 50%.
Factors that influence GMP:
- Subscription levels — Higher subscription typically drives GMP up
- Market conditions — Bullish markets tend to boost GMP across all IPOs
- Company fundamentals — Strong financials and growth potential attract premium
- Industry sentiment — Positive outlook for the sector can increase demand
- IPO pricing — Reasonably priced IPOs relative to peers tend to command higher GMP
Disclaimer: GMP is an unofficial metric from the grey market and is not regulated by SEBI or any stock exchange. GMP values fluctuate frequently and should not be the sole basis for investment decisions. Always consider company fundamentals, financial health, and your own risk appetite before investing in any IPO.
Related IPO
No comments yet. Be the first to share your opinion!